NEDD4 and ductal breast carcinoma in situ: Based on our studies, NEDD4 expression gradually increases in line with BC progression, from normal tissues, DCIS, IDC without lymph node metastasis to BCLNM tumors, which is a well-established clinical model for BC progression [5].